SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-24-000077
Filing Date
2024-01-02
Accepted
2024-01-02 20:06:10
Documents
2
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp204636_3-azelby.html 3  
1 FORM 3 dp204636_3-azelby.xml 3 4013
2 EXHIBIT 24 dp204636_ex2400.htm EX-24 7893
  Complete submission text file 0000950103-24-000077.txt   13349
Mailing Address 307 WESTLAKE AVE. NORTH, STE 300 SEATTLE WA 98109
Business Address
Azelby Robert (Reporting) CIK: 0001656998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39071 | Film No.: 24504087

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)